Navigation Links
Organovo Reports Q1 Fiscal 2014 Results, Provides Business Update
Date:8/12/2013

SAN DIEGO, Aug. 12, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo") a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has reported on its financial results for the three-month period ended June 30, 2013 and provides a business update.

Recent Corporate Highlights

  • Presented data on first fully cellular 3D Bioprinted Liver Tissue
  • Listed common stock on the NYSE MKT
  • Successfully completed $46.6 million public offering
  • Appointed Tamar D. Howson to the Company's Board of Directors 
  • Nominated Richard Heyman Ph.D. for election to the Board of Directors at the upcoming Annual Meeting
  • Changed fiscal year-end from December 31st to March 31st
  • Organovo and Methuselah Foundation Announced Funding of Bioprinting Research at Research Institutions
  • On April 26th, Organovo described the first fully cellular 3D bioprinted liver tissue, having presented data on its  in vitro three-dimensional liver at the 2013 Experimental Biology conference in Boston, Massachusetts. For the first time, human liver tissues were generated that were truly three-dimensional, being up to 500 microns in thickness in the smallest dimension, and consisting of multiple cell types arranged in defined spatial patterns that reproduce key elements of native tissue architecture and demonstrated excellent functional characteristics that replicates human biology better than what has come before. 

    On July 9th, Organovo announced that its common stock had been approved for listing on the New York Stock Exchange MKT.  Trading commenced on the NYSE MKT on July 11th, and Company's CEO Keith Murphy rang the opening bell at the NYSE on July 15 th.

    On August 7 th, Organovo successfully completed a public offering in which it raised gross pro
    '/>"/>

    SOURCE Organovo Holdings, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
    2. Organovo Announces the Nomination of Richard A. Heyman to Board of Directors
    3. Organovo Rings Opening Bell On New York Stock Exchange
    4. OTC Markets Group Congratulates Organovo Holdings on Move to NYSE MKT
    5. Organovo To List Common Stock On New York Stock Exchange MKT
    6. Organovo Appoints Tamar D. Howson to Board of Directors
    7. Organovo to Present at the 12th Annual Needham Healthcare Conference
    8. Organovo Partners With ZenBio to Create 3D Tissue Models
    9. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
    10. Organovo Reports Q3 2012 Financial Results, Provides Business Update
    11. Organovo To Present At Lazard Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ) ... Outlook 2015: New Therapy Ventures Pave the Way for ... All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen ... given a positive return and hence increased the interest ... select therapy/niche indication where the high treatment cost justifies ...
    (Date:3/5/2015)... e2b teknologies , a premier ... Northeast Ohio, today announced a leading independent multi-specialty physician ... upgrade to the latest version of Sage 100 ... of its kind in the region, the organization has ... so efficiency and data accessibility are paramount to their ...
    (Date:3/5/2015)... Southlake, Texas (PRWEB) March 05, 2015 ... treatment of acute and chronic orthopedic conditions such ... runner’s knee, tennis elbow, and joint pain due ... also be administered during orthopedic surgeries to promote ... patented scientific advances in nearly pain-free bone marrow ...
    (Date:3/4/2015)... -- In an article published and posted online today, ... review the clinical aspects of diseases caused by 5 ... article, "Clinical Management of Potential Bioterrorism-Related Conditions," was published ... New England Journal of Medicine . ... Tom Inglesby—review the clinical management of conditions resulting from ...
    Breaking Biology Technology:Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5Latest Clinical Information On Bioterrorism Threats 2
    ... Therapeutics (Euronext: AMT), a leader in the field ... Board has decided to,propose Dr. George Morstyn to ... General Meeting of shareholders on April 16, 2008. ... Senior Vice President of Development at,Amgen, was a ...
    ... Fla., April 1, 2008 MiMedx Group, Inc.,(OTC ... (OTC Bulletin,Board: AYXC), today reported that the contemplated ... Florida and related name change, to,MiMedx Group, Inc., ... 2008. As a result of the reverse split ...
    ... VWR International,LLC, a leading global laboratory supply company, ... a UK scientific laboratory,supply distributor., Jencons is ... equipment,and consumables with 110 employees. Based in the ... and North America. The Company has annual,revenues of ...
    Cached Biology Technology:Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board 2Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board 3MiMedx Group Announces Post-split Name Change 2MiMedx Group Announces Post-split Name Change 3VWR International, LLC Acquires Jencons (Scientific) Ltd, UK 2
    (Date:2/5/2015)...  It is gratifying to see that the Obama ... science as a means to better understand human biology, ... was honored to participate in today,s White House event ... Since the 1980s my teams have been ... sequenced genome of a free living organism, the first ...
    (Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
    (Date:1/22/2015)...  A man-made form of insulin delivered by nasal spray ... adults with mild cognitive impairment and Alzheimer,s disease dementia, ... Wake Forest Baptist Medical Center. The study,s ... impairment (MCI) or mild to moderate Alzheimer,s dementia (AD). ...
    Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
    ... researchers from across North America have been awarded ... at Stanford University,s Woods Institute for the Environment, ... to help academic scientists make their knowledge accessible ... selects up to 20 mid-career academic environmental researchers ...
    ... is free of charge for all holders of a ... have access to the onsite press facilities, including a ... staff will also be able to assist you in ... You can register for free online at: http://www.eular.org/congress_press_registration.cfm ...
    ... University in St. Louis scientists are imitating nature as they ... orthopedic surgery: reattaching tendon to bone. Their goal is ... rotator cuff is the group of four tendons and muscles ... tendons tear or detach from the bone. Commonly thought ...
    Cached Biology News:20 researchers selected as 2011 Leopold Leadership Fellows 220 researchers selected as 2011 Leopold Leadership Fellows 320 researchers selected as 2011 Leopold Leadership Fellows 4Biomimetic patch to be tested on tricky tendon-to-bone repairs 2Biomimetic patch to be tested on tricky tendon-to-bone repairs 3Biomimetic patch to be tested on tricky tendon-to-bone repairs 4
    Mouse polyclonal antibody to PRDM2 - PR domain containing 2, with ZNF domain...
    Hepatocyte Differentiation Environment...
    Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
    ...
    Biology Products: